Central Vein
- XW143 - Percutaneous
- XW1432
- XW14325 - Transfusion Central Vein to New Technology Group 5 with Plasma, Convalescent (Nonautologous), Percutaneous Approach
- XW1437
- XW1437A - Transfusion Central Vein to New Technology Group 10 with Marnetegragene Autotemcel, Percutaneous Approach
- XW143B
- XW143B8 - Transfusion Central Vein to New Technology Group 8 with Betibeglogene Autotemcel, Percutaneous Approach
- XW143C
- XW143C8 - Transfusion Central Vein to New Technology Group 8 with Omidubicel, Percutaneous Approach
- XW143D
- XW143D7 - Transfusion Central Vein to New Technology Group 7 with High-Dose Intravenous Immune Globulin, Percutaneous Approach
- XW143E
- XW143E7 - Transfusion Central Vein to New Technology Group 7 with Hyperimmune Globulin, Percutaneous Approach
- XW143F
- XW143F8 - Transfusion Central Vein to New Technology Group 8 with OTL-103, Percutaneous Approach
- XW143G
- XW143G8 - Transfusion Central Vein to New Technology Group 8 with OTL-200, Percutaneous Approach
- XW143H
- XW143H9 - Transfusion Central Vein to New Technology Group 9 with Lovotibeglogene Autotemcel, Percutaneous Approach
- XW143J
- XW143J8 - Transfusion Central Vein to New Technology Group 8 with Exagamglogene Autotemcel, Percutaneous Approach